INS and metabolic dysfunction-associated steatotic liver disease: In their study, Smith et al. showed that the hepatic de novo lipogenesis (DNL), a key factor in NAFLD-related steatosis, escalates concurrently with the rise in insulin-resistant glucose metabolism (18).